LABA/LAMA combination inhalers (COPD only)
Choice Drug Dosage Formulary Choices Anoro Ellipta ®▼ DPI
55/22
(umeclidinium /vilanterol) Dose: One inhalation daily
OrDuaklir Genuair®▼ DPI 340/12 (aclidinium/formoterol)
Dose: One inhalation twice daily
OrSpiolto Respimat® soft mist 2.5/2.5 inhalation solution (tiotropium/olodaterol)
Dose: Two inhalations once daily
OrUltibro Breezhaler® DPI 85/43 inhalation powder capsules with device (indacaterol/glycopyrronium)
Dose: One inhalation daily
| Choice | Drug | Dosage |
|---|---|---|
| Formulary Choices | Anoro Ellipta ®▼ DPI 55/22 (umeclidinium /vilanterol) | Dose: One inhalation daily |
Or | ||
Duaklir Genuair®▼ DPI 340/12 (aclidinium/formoterol) | Dose: One inhalation twice daily | |
Or | ||
Spiolto Respimat® soft mist 2.5/2.5 inhalation solution (tiotropium/olodaterol) | Dose: Two inhalations once daily | |
Or | ||
Ultibro Breezhaler® DPI 85/43 inhalation powder capsules with device (indacaterol/glycopyrronium) | Dose: One inhalation daily |
Prescribing Notes
- Consider a LAMA/LABA combination in patients with severe breathlessness symptoms and low risk of exacerbations before considering addition of ICS.
- All LABA/LAMA combination inhalers are less costly than the combined costs of the single inhalers and may be more convenient for patients.